It reveals the role that ITCH/ TGFβ1/SMADs pathway inhibits myocardial fibrosis, indicating that Calhex 231 may represent a novel drug for treating dilated cardiomyopathy 84. The gene discussed is TGFB1; the disease is dilated cardiomyopathy.